Literature DB >> 7682164

Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity.

K C Watret1, J A Whitelaw, K S Froebel, A G Bird.   

Abstract

The CD8+ T cell population is believed to play an important role in the control of viral infection, both for suppression of viral replication and for cytotoxic activity against viral infected cells. Elevated numbers of CD8+ T cells have been demonstrated in HIV infection, and CD8+ cytotoxic T cell (CTL) activity is associated with the early, asymptomatic stage of disease. We investigated the phenotypic characteristics of the CD8 population, in whole blood, in HIV disease and determined the predominant CD8+ subpopulation involved in anti-HIV CTL activity. We found that CD8+ T cells co-expressing markers of activation (HLA-DR), memory (CD45RO, CD29), and cytotoxic activity (S6F1) were significantly elevated in the early stages of disease, while the numbers of naive (CD45RA) cells remained unchanged. Progression to AIDS resulted in an overall loss of absolute CD8+ T cells, though the percentages of CD8+ HLA-DR+ and CD8+ S6F1+ remained elevated. In contrast to patients in the late stages of disease, anti-HIVgag CTL activity, following in vitro stimulation, was present in most HIV+ asymptomatic subjects and was associated with an expansion of CD8+ HLA-DR+ and CD8+ CD45RO+ cells. The absence of CTL activity was associated with a reduced ability of these populations to expand in vitro and with a significant loss of peripheral CD4+ T cells, independent of clinical stage. We suggest that CD8+ expressing HLA-DR+ CD45RO+ and S6F1+ play an important role in anti-HIV cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682164      PMCID: PMC1554866          DOI: 10.1111/j.1365-2249.1993.tb05953.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  The functional heterogeneity of CD8+ cells defined by anti-CD45RA (2H4) and anti-CD29 (4B4) antibodies.

Authors:  S Sohen; D M Rothstein; T Tallman; D Gaudette; S F Schlossman; C Morimoto
Journal:  Cell Immunol       Date:  1990-06       Impact factor: 4.868

2.  Interconversion of CD45R subsets of CD4 T cells in vivo.

Authors:  E B Bell; S M Sparshott
Journal:  Nature       Date:  1990-11-08       Impact factor: 49.962

3.  Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells.

Authors:  D L Wallace; P C Beverley
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

4.  Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.

Authors:  G Pantaleo; S Koenig; M Baseler; H C Lane; A S Fauci
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

5.  Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs.

Authors:  R A Koup; J L Sullivan; P H Levine; D Brettler; A Mahr; G Mazzara; S McKenzie; D Panicali
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

6.  CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity.

Authors:  G Pantaleo; A De Maria; S Koenig; L Butini; B Moss; M Baseler; H C Lane; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.

Authors:  D F Nixon; A R Townsend; J G Elvin; C R Rizza; J Gallwey; A J McMichael
Journal:  Nature       Date:  1988-12-01       Impact factor: 49.962

8.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

Authors:  A N Akbar; L Terry; A Timms; P C Beverley; G Janossy
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

9.  Class II (DR) antigen expression on CD8+ lymphocyte subsets in acquired immune deficiency syndrome (AIDS).

Authors:  H W Ziegler-Heitbrock; D Stachel; T Schlunk; L Gürtler; W Schramm; M Fröschl; J R Bogner; G Riethmüller
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

10.  A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.

Authors:  H Tsubota; C I Lord; D I Watkins; C Morimoto; N L Letvin
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

View more
  7 in total

1.  Age-related ranges of memory, activation, and cytotoxic markers on CD4 and CD8 cells in children.

Authors:  M C Aldhous; G M Raab; K V Doherty; J Y Mok; A G Bird; K S Froebel
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

2.  Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection.

Authors:  M C Aldhous; K C Watret; J Y Mok; A G Bird; K S Froebel
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

3.  Depression in caregivers of demented patients is associated with altered immunity: impaired proliferative capacity, increased CD8+, and a decline in lymphocytes with surface signal transduction molecules (CD38+) and a cytotoxicity marker (CD56+ CD8+).

Authors:  S Castle; S Wilkins; E Heck; K Tanzy; J Fahey
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

4.  Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes.

Authors:  A Kalinkovich; G Livshits; H Engelmann; N Harpaz; R Burstein; M Kaminsky; D Wallach; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

5.  Presence of CD3+CD8+Bcl-2(low) lymphocytes undergoing apoptosis and activated macrophages in lymph nodes of HIV-1+ patients.

Authors:  M Bofill; W Gombert; N J Borthwick; A N Akbar; J E McLaughlin; C A Lee; M A Johnson; A J Pinching; G Janossy
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

6.  A monoclonal antibody against lymphocyte function-associated antigen-1 decreases HIV-1 replication by inducing the secretion of an antiviral soluble factor.

Authors:  Jenna Rychert; Lindsay Jones; Graham McGrath; Sue Bazner; Eric S Rosenberg
Journal:  Virol J       Date:  2013-04-18       Impact factor: 4.099

7.  Abnormalities in subset distribution, activation, and differentiation of T cells isolated from large intestine biopsies in HIV infection. The Berlin Diarrhoea/Wasting Syndrome Study Group.

Authors:  T Schneider; R Ullrich; C Bergs; W Schmidt; E O Riecken; M Zeitz
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.